Keyword: AAEP

  • Medication Panel Agrees to Move Forward on Plan

    Representatives from about 20 industry organizations unanimously endorsed a plan to develop a national medication policy during a teleconference Jan. 28. The action followed the first Racehorse Medication Summit, held Dec. 4, 2001, in Tucson, Ariz.

  • National HBPA Takes Further Action on Medication

    The board of the National Horsemen's Benevolent and Protective Association, during its winter convention in Las Vegas, Nev., Jan. 22-24, passed two motions tied to medication issues: One calls for more representation in follow-up meetings to the Racehorse Medication Summit, while the other seeks official positions from affiliates on use of race-day therapeutic medication.

  • Text of Racehorse Medication Summit Report

    The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.

  • Summit Report Has January Release Date

    The official report on the Dec. 4 Racehorse Medication Summit organized by the American Association of Equine Practitioners could be released Jan. 4. The document is expected to provide information on consensus reached by the more than 30 industry officials who participated.

  • TOC Agrees on Need for Medication Consensus

    California is on board with a nationwide push for a consensus on racehorse medication, the president of the Thoroughbred Owners of California reported to his board the week of Dec. 10. But the TOC does have its own opinions on some of the specifics.

  • 'Super-Test' Results, Round Two, Due in January

    The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.

  • Summit Comes Down to Time and Money

    In the aftermath of Tuesday's Racehorse Medication Summit, it was all about time and money. Participants said they wouldn't have much more to say until the official minutes of the meeting are released, and that the success of any proposal hinges on a funding mechanism.

  • Trainer John Ward: "I really didn't have a lot to say, because the train was running on a straight track."

    Medication Summit: Consensus, But Very Few Details

    Participants at Tuesday's Racehorse Medication Summit in Tucson, Ariz., reached a consensus on medication, drug-testing, security, and enforcement, but said much of any future policy depends on scientific determinations. The group of about 30 industry officials did agree on the need for a uniform medication policy and decision levels for therapeutic medications, but specifics weren't discussed.

  • Industry Hopes For Starting Point on Drugs

    Racing industry participants expressed hope Tuesday morning that a five-hour facilitated session on medication would at least serve as a starting point toward uniformity. No one expected radical changes in current policies that vary by jurisdiction in the United States.

  • Approaching the Gate

    <i>By Dr. C. Wayne McIlwraith</i> -- The industry wants horse racing to increase in popularity and achieve the status of a major league sport. The time is right for us all to come together and reach consensus on medication issues.

  • AAEP Prepared for Medication Summit

    The American Association of Equine Practitioners has spent many hours over the past year getting ready for the Dec. 4 medication summit that will be part of the University of Arizona Race Track Industry Program's Symposium on Racing. "We hope for the first time to bring together key stakeholders in the racing industry to specifically discuss racehorse medication," said Dr. Wayne McIlwraith, 2001 president of the AAEP.

  • Summit Has Helped Move Medication to Fore

    Officials with the American Association of Equine Practitioners acknowledge that their "Racehorse Medication Summit" planned for Dec. 4 appears to have moved some organizations to action. But they admit the complex issue of medication and drug-testing can't be addressed in one day.

  • AAEP Plans Medication Summit

    A wide-ranging group of industry representatives will take part in the Racehourse Medication Summit during the University of Arizona Race Track Industry Program's Annual Symposium on Racing. The medication summit, sponsored by the American Association of Equine Practitioners (AAEP), is planned for Dec. 4.

  • AAEP To Hold Medication Summit

    The next Symposium on Racing will include an all-day meeting on medication to be conducted by the American Association of Equine Practitioners. The Dec. 4 "summit" will look at the administration of therapeutic medications and discuss the standards and policies the industry should employ when treating horses for racing.

  • Safe Delivery Tips

    Most equine births are uneventful, but there are some steps you can take to make sure your mare's labor and delivery are safe and successful.

  • AAEP Preview

    The results of a landmark, three-year study on radiographic changes in Thoroughbred yearlings will be presented during the American Association of Equine Practitioners annual convention.

  • AAEP Adopts New Medication Policy

    The American Association of Equine Practitioners has adopted a new policy regarding therapeutic medication in racehorses that, among other things, calls for a ban on all race day medications other than the diuretic furosemide used to treat internal bleeding.